← Back to overview

TECH Bio-Techne Corp

Life Sciences Tools & Services · $71.60 -0.24%
Price Alert:
Price & Volume
RSI (14)
MACD (12, 26, 9)

Compare

Shows % change over the period so different-priced stocks can be compared fairly.

Technical Indicators

RSI (14)
73.7
Relative Strength Index (RSI): measures how fast and how much the price has moved recently, on a 0-100 scale. Above 70 is often called "overbought" (may be due for a pause or pullback); below 30 is "oversold" (may be due for a bounce). It is not a guarantee either way.
SMA 20 / 50 / 200
71.24 / 59.12 / —
Moving Averages (SMA): the average closing price over the last N days, smoothing out day-to-day noise. When price trades above its moving averages, and shorter averages are above longer ones, it is generally read as a healthier trend.
MACD / Signal
3.43 / 4.04
MACD: compares two moving averages (12-day and 26-day) to gauge momentum. When the MACD line crosses above its signal line, momentum is turning up; crossing below suggests momentum turning down.

Fundamentals

P/E
102.3
Price-to-Earnings ratio: how many dollars investors pay for $1 of the company's annual profit. Higher usually means the market expects faster growth (or the stock is expensive); lower can mean it's cheap — or that growth is expected to slow.
Market Cap
11.16B
Market Capitalization: the total value of all the company's shares — share price × number of shares. A rough measure of company size.
Div Yield
0.45%
Dividend Yield: the annual cash dividend paid to shareholders, as a percentage of the current share price.
52-Week Range
43.20 – 72.16
52-Week Range: the lowest and highest price the stock has traded at over the last year. Where the price sits in this range hints at recent strength or weakness.

Trend Analysis

Bio-Techne Corp is trading at $71.60, -0.24% versus the previous close. The price is near its 52-week high — the top of its recent trading range.
Overbought territory (RSI > 70) — the stock has risen quickly and could be due for a pause.
MACD is below its signal line — momentum currently leans negative.
Combine this reading with the fundamentals below before forming a view — no single indicator is a guarantee of what happens next.

Latest News

What to Expect From Bio-Techne's Next Quarterly Earnings Report
Barchart · 2026-07-20 12:12
Q1 Earnings Outperformers: Bio-Techne (NASDAQ:TECH) And The Rest Of The Research Tools & Consumables Stocks
StockStory · 2026-07-16 19:13
RBC Capital Downgrades Bio-Techne to Sector Perform From Outperform, Adjusts Price Target to $73 From $62
MT Newswires · 2026-07-09 11:24
Bio-Techne Expands AI-Engineered Designer Protein Portfolio
MT Newswires · 2026-07-08 11:10
Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio
PR Newswire · 2026-07-08 10:30
Evercore ISI Downgrades Bio-Techne to In Line From Outperform, Maintains $73 Price Target
MT Newswires · 2026-07-06 11:12
SkylineDx’s Merlin CP-GEP Granted FDA Breakthrough Device Designation
Exec Edge · 2026-07-01 21:41
Piper Sandler Adjusts Bio-Techne Price Target to $73 From $60, Maintains Neutral Rating
MT Newswires · 2026-07-01 12:00
Educational information only. Nothing here is investment advice — always do your own research and consider talking to a licensed financial advisor before buying or selling.
Data: Yahoo Finance, refreshed periodically and cached locally.